Oxidative phosphorylation is a pivotal therapeutic target of fibrodysplasia ossificans progressiva. [PDF]
酸化的リン酸化の抑制がFOPの新たな治療法に繋がる可能性. 京都大学プレスリリース. 2024-03-11.Heterotopic ossification (HO) is a non-physiological bone formation where soft tissue progenitor cells differentiate into chondrogenic cells.
Sun L +10 more
europepmc +3 more sources
Intermittent and Short-Term Empirical Ruxolitinib Regimen for Steroid-Refractory Flareups of Fibrodysplasia Ossificans Progressiva. [PDF]
ABSTRACT Fibrodysplasia ossificans progressiva (FOP) is an ultra‐rare genetic disorder with inflammation‐related flare‐ups resulting in catastrophic heterotopic ossification (HO). Janus‐associated kinase (JAK) inhibitors may have had a blocking effect on bone formation in controlling FOP flare‐ups by blocking multiple inflammatory signaling pathways ...
Chen RL +4 more
europepmc +2 more sources
Congenital hallux valgus occurs in Fibrodysplasia Ossificans Progressiva and BMPR1B-associated dysplasia: an important distinction. [PDF]
Background: Fibrodysplasia Ossificans Progressiva (FOP; OMIM #135100) is an ultrarare genetic disorder characterised by congenital bilateral hallux valgus (CBHV), intermittent soft tissue swellings and progressive heterotopic ossification.
Shirodkar D +5 more
europepmc +3 more sources
Fibrodysplasia Ossificans Progressiva
Abstract: Fibrodysplasia Ossificans Progressiva (FOP), commonly known as Stoneman Syndrome, is an ultra-rare genetic disorder characterized by the progressive ossification of soft tissues, leading to the formation of a secondary skeleton. This paper provides a comprehensive analysis of FOP, examining its epidemiology, pathophysiology, clinical ...
Agrawal U, Tiwari V.
europepmc +4 more sources
Fibrodysplasia ossificans progressiva [PDF]
Fibrodysplasia ossificans progressiva (FOP), a rare and disabling genetic condition of congenital skeletal malformations and progressive heterotopic ossification (HO), is the most catastrophic disorder of HO in humans. Episodic disease flare-ups are precipitated by soft tissue injury, and immobility is cumulative.
Frederick S, Kaplan +7 more
openaire +3 more sources
Fibrodysplasia Ossificans Progressiva: what have we achieved and where are we now? follow-up to the 2015 Lorentz Workshop [PDF]
Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare progressive genetic disease effecting one in a million individuals. During their life, patients with FOP progressively develop bone in the soft tissues resulting in increasing immobility and ...
Bocciardi, Renata +34 more
core +5 more sources
The Special Issue on “Fibrodysplasia Ossificans Progressiva: Studies on Disease Mechanism towards Novel Therapeutic Approaches” has published interesting and useful review articles and original experimental articles on fibrodysplasia ossificans ...
Roberto Ravazzolo
doaj +1 more source
Fibrodysplasia Ossificans Progressiva: A rare case series
Background: Fibrodysplasia ossificans progressiva is a rare autosomal dominant connective tissue disorder with a prevalence of 2 per million individuals.
Lokesh kumar Sekaran +3 more
doaj +1 more source
Early Recognition of Fibrodysplasia Ossificans Progressiva-Important For the Clinician
Fibrodysplasia ossificans progressiva is a rare disorder of heterotopic ossification. Procedures like biopsy and surgery are known to be aggravating factors in promoting heterotopic ossification Clues to clinical diagnosis may therefore be a great ...
Ankur Singh +3 more
doaj +3 more sources
Knowledge and awareness about fibrodysplasia ossificans progressiva among dental students
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder which is autosomal dominant distinguished by congenital malformations of large toes and flare ups, etc. It is a disorder of connective tissue, with heterotopic ossifications seen with
L Akshayaa +3 more
doaj +1 more source

